Geode Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$98.9M Buy
2,994,445
+56,961
+2% +$1.88M 0.01% 1033
2025
Q1
$118M Buy
2,937,484
+96,146
+3% +$3.86M 0.01% 880
2024
Q4
$134M Sell
2,841,338
-7,246
-0.3% -$341K 0.01% 821
2024
Q3
$150M Buy
2,848,584
+109,938
+4% +$5.81M 0.01% 746
2024
Q2
$148M Buy
2,738,646
+491,481
+22% +$26.6M 0.01% 699
2024
Q1
$158M Buy
2,247,165
+157,040
+8% +$11M 0.01% 688
2023
Q4
$175M Buy
2,090,125
+111,760
+6% +$9.33M 0.02% 595
2023
Q3
$58.3M Buy
1,978,365
+69,134
+4% +$2.04M 0.01% 1134
2023
Q2
$62.3M Buy
1,909,231
+174,535
+10% +$5.69M 0.01% 1087
2023
Q1
$61M Buy
1,734,696
+76,846
+5% +$2.7M 0.01% 1045
2022
Q4
$76M Buy
1,657,850
+66,392
+4% +$3.04M 0.01% 870
2022
Q3
$77.1M Buy
1,591,458
+107,936
+7% +$5.23M 0.01% 801
2022
Q2
$58.3M Buy
1,483,522
+11,611
+0.8% +$456K 0.01% 1002
2022
Q1
$54.2M Buy
1,471,911
+43,289
+3% +$1.59M 0.01% 1198
2021
Q4
$65.1M Buy
1,428,622
+30,574
+2% +$1.39M 0.01% 1109
2021
Q3
$50M Buy
1,398,048
+187,626
+16% +$6.71M 0.01% 1277
2021
Q2
$24M Buy
1,210,422
+52,294
+5% +$1.03M ﹤0.01% 1846
2021
Q1
$26.9M Buy
1,158,128
+102,567
+10% +$2.39M ﹤0.01% 1687
2020
Q4
$21.9M Buy
1,055,561
+52,615
+5% +$1.09M ﹤0.01% 1663
2020
Q3
$21.7M Buy
1,002,946
+131,880
+15% +$2.86M ﹤0.01% 1484
2020
Q2
$20.5M Buy
871,066
+13,310
+2% +$314K ﹤0.01% 1493
2020
Q1
$10.1M Buy
857,756
+57,784
+7% +$681K ﹤0.01% 1736
2019
Q4
$8.49M Buy
799,972
+8,303
+1% +$88.1K ﹤0.01% 2129
2019
Q3
$9.01M Buy
791,669
+37,536
+5% +$427K ﹤0.01% 2011
2019
Q2
$8.48M Buy
754,133
+82,998
+12% +$934K ﹤0.01% 2064
2019
Q1
$5.43M Buy
671,135
+85,592
+15% +$692K ﹤0.01% 2284
2018
Q4
$3.7M Buy
585,543
+70,954
+14% +$448K ﹤0.01% 2409
2018
Q3
$5.07M Buy
514,589
+18,139
+4% +$179K ﹤0.01% 2349
2018
Q2
$4.12M Buy
496,450
+62,330
+14% +$517K ﹤0.01% 2434
2018
Q1
$3.13M Buy
434,120
+5,572
+1% +$40.1K ﹤0.01% 2513
2017
Q4
$3.49M Buy
428,548
+6,813
+2% +$55.5K ﹤0.01% 2430
2017
Q3
$6.12M Sell
421,735
-26,541
-6% -$385K ﹤0.01% 2074
2017
Q2
$5.42M Buy
448,276
+151,593
+51% +$1.83M ﹤0.01% 2094
2017
Q1
$3.81M Buy
296,683
+11,747
+4% +$151K ﹤0.01% 2270
2016
Q4
$3.46M Buy
284,936
+11,268
+4% +$137K ﹤0.01% 2293
2016
Q3
$2.51M Buy
273,668
+1,817
+0.7% +$16.7K ﹤0.01% 2424
2016
Q2
$2.58M Sell
271,851
-6,979
-3% -$66.2K ﹤0.01% 2322
2016
Q1
$1.97K Sell
278,830
-47,250
-14% -$333 ﹤0.01% 2476
2015
Q4
$3.41M Buy
326,080
+41,767
+15% +$437K ﹤0.01% 2133
2015
Q3
$1.9M Buy
284,313
+87,835
+45% +$588K ﹤0.01% 2477
2015
Q2
$1.32M Buy
196,478
+1,402
+0.7% +$9.42K ﹤0.01% 2753
2015
Q1
$1.32M Buy
195,076
+33,434
+21% +$227K ﹤0.01% 2704
2014
Q4
$1.29M Buy
161,642
+231
+0.1% +$1.85K ﹤0.01% 2683
2014
Q3
$568K Buy
161,411
+3,088
+2% +$10.9K ﹤0.01% 3106
2014
Q2
$756K Buy
158,323
+2,776
+2% +$13.3K ﹤0.01% 2966
2014
Q1
$1.48M Buy
155,547
+32,582
+26% +$309K ﹤0.01% 2528
2013
Q4
$799K Buy
122,965
+1,833
+2% +$11.9K ﹤0.01% 2853
2013
Q3
$919K Buy
121,132
+29,644
+32% +$225K ﹤0.01% 2640
2013
Q2
$1.06M Buy
+91,488
New +$1.06M ﹤0.01% 2432